Trial Profile
A Randomized, Double-blind, Placebo- and Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged-release Tablets in Subjects with Moderate to Severe, Chronic Nonmalignant Pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Aug 2021
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary) ; Oxycodone
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Mundipharma GmbH
- 12 Nov 2013 Integrated European Clinical Trials Database record.
- 12 Nov 2013 New trial record